Tom Soloway

2016

In 2016, Tom Soloway earned a total compensation of $468.7K as Senior Vice President and Chief Financial Officer at Audentes Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$108,150
Salary$360,500
Total$468,650

Soloway received $360.5K in salary, accounting for 77% of the total pay in 2016.

Soloway also received $108.2K in non-equity incentive plan.

Rankings

In 2016, Tom Soloway's compensation ranked 11,402nd out of 14,075 executives tracked by ExecPay. In other words, Soloway earned more than 19.0% of executives.

ClassificationRankingPercentile
All
11,402
out of 14,075
19th
Division
Manufacturing
4,443
out of 5,489
19th
Major group
Chemicals And Allied Products
1,592
out of 1,895
16th
Industry group
Drugs
1,287
out of 1,538
16th
Industry
Biological Products, Except Diagnostic Substances
226
out of 279
19th
Source: SEC filing on April 27, 2017.

Soloway's colleagues

We found three more compensation records of executives who worked with Tom Soloway at Audentes Therapeutics in 2016.

2016

Matthew Patterson

Audentes Therapeutics

Chief Executive Officer

2016

Thomas Soloway

Audentes Therapeutics

Chief Financial Officer

2016

Natalie Holles

Audentes Therapeutics

Chief Operating Officer

You may also like